[Demetrin (prazepam) in clinical therapy (author's transl)].
D000328:Adult; D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy*; D011222:Prazepam / Q000009:adverse effects / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014149:Tranquilizing Agents; D011222:Prazepam
Demetrin (Prazepam) in der klinischen Therapie. Erfahrungen mit einem neuen Tranquilizer.